Mode
Text Size
Log in / Sign up

Modeling suggests B.1.1.7 variant may increase U.S. pandemic trajectory in coming months

Modeling suggests B.1.1.7 variant may increase U.S. pandemic trajectory in coming months
Photo by Navy Medicine / Unsplash
Key Takeaway
Note: Preliminary modeling suggests B.1.1.7 may worsen U.S. pandemic trajectory; interpret cautiously.

A modeling report from the United States examined the potential impact of SARS-CoV-2 variants of concern, including the B.1.1.7 variant. The report concluded that the B.1.1.7 variant has the potential to increase the U.S. pandemic trajectory in the coming months. No specific effect size, absolute numbers, confidence intervals, or p-values were reported for this finding.

No information was provided regarding specific interventions, exposures, or comparators studied. The report did not include details on study design, sample size, follow-up duration, or primary and secondary outcomes. Safety, tolerability, and adverse event data were not reported.

Key limitations include the report's unspecified methodology and lack of peer review. The absence of quantitative data and a formal study design restricts the strength of the conclusions. The practice relevance of this finding is not reported, and clinicians should treat this as preliminary situational awareness rather than definitive evidence for clinical decision-making.

Study Details

EvidenceLevel 5
PublishedJan 2021
View Original Abstract ↓
This report describes SARS-CoV-2 variants of concern, including the B.1.1.7 variant, and modeling data indicating that B.1.1.7 has the potential to increase the U.S. pandemic trajectory in the coming months.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.